retatrutide investigational drug weight loss UK: New Triple-Agonist Injection Explained Retatrutide | Curely
Description
The product arrived sealed, labeled, and packed neatly. Ella R
Received 2021-3-1
The Science: GLP-1 vs
A diferencia de los mono y dual agonistas, semaglutida y tirzepatida, la retatrutida introduce el triple agonismo al dirigirse simultneamente a los receptores del pptido similar al glucagn-1 ( GLP-1 ), del polipptido insulinotrpico dependiente de glucosa ( GIP ) y, de manera crucial, al receptor de glucagn (GCGR)
This makes it a valuable tool for patients struggling with obesity or related conditions such as type 2 diabetes
